Latest Commercialization News

Syrah Resources has clarified its offtake agreement with Tesla, extending the final qualification deadline for its Vidalia anode active material facility to February 2027. Both companies continue advancing towards commercial sales despite the extended timeline.

Orbital Corporation has appointed Stephen Pearce as CEO, marking a strategic shift from engine development to commercialising propulsion and flight management systems for defence UAVs.

Recce Pharmaceuticals has secured a significant patent acceptance in China for its RECCE® anti-infectives, broadening its intellectual property footprint in the world’s second-largest pharmaceutical market.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Axel REE Limited has responded to ASX Compliance queries confirming the timely disclosure of its latest rare earth element drilling results at the Poços de Caldas Caldera, emphasizing the incremental nature of the findings and ongoing compliance with listing rules.

State Gas Limited faces a land access blockade at its Rolleston West Project, prompting legal action to resume critical drilling operations. The dispute threatens to delay progress on promising coal seam gas assets in Queensland's Bowen Basin.

NoviqTech has extended its partnership with Hedera Foundation for five more years, backed by a milestone-driven grant to accelerate adoption of its blockchain sustainability platforms.

Jade Gas Holdings has completed Mongolia’s inaugural horizontal coal bed methane wells at the Red Lake field, setting the stage for initial gas production by early June 2025. The company is advancing commercial partnerships to leverage this milestone for cleaner energy solutions in the South Gobi region.

TruScreen Group Ltd reports a dip in FY25 sales but forecasts a robust rebound in FY26 driven by resumed programs and expansion in key emerging markets. Strategic partnerships and AI-enabled technology underpin its growth ambitions.

TruScreen Group Limited reported a 19% revenue decline in FY2025 due to delayed rollouts in key emerging markets but anticipates a strong rebound with FY2026 sales forecast to exceed NZ$2.8 million.

Ionic Rare Earths has signed a pivotal MOU with EMR to develop a circular supply chain for rare earth magnets, supporting its Belfast recycling plant and the UK’s net-zero ambitions.

Rhythm Biosciences has successfully validated its second-generation ColoSTAT® Beta assay, confirming its readiness for commercial application in colorectal cancer detection. The Beta kit offers improved precision and faster turnaround times compared to its predecessor.